The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.50
Bid: 54.00
Ask: 57.00
Change: 2.50 (4.50%)
Spread: 3.00 (5.556%)
Open: 55.50
High: 58.00
Low: 58.00
Prev. Close: 55.50
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of New Shares

23 Jan 2020 11:45

RNS Number : 7499A
Baronsmead Second Venture Trust PLC
23 January 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

Baronsmead Second Venture Trust plc

23 January 2020

Issue of New Shares pursuant to the Offer for Subscription

The Board of Baronsmead Second Venture Trust plc (the "Company") announced on 4 October 2019 that it had published a prospectus in conjunction with Baronsmead Venture Trust plc in relation to an offer for subscription to each raise up to £20 million in aggregate (before costs) with an over-allotment facility to each raise up to a further £5 million in aggregate (the "Offer"). The Company announced on 20 November 2019 that 11,596,119 New Shares would be issued at an issue price of 78.90 pursuant to the first allotment under the Offer.

In accordance with its discretion under the Prospectus, the Company further announced on 13 December 2019 that the date of the second allotment under the Offer had been amended and is to take place on 24 January 2020. Accordingly, New Shares in the Company issued under the second allotment of the Offer will be issued at an issue price of 84.80 pence and 5,978,704 New Shares in aggregate will be issued pursuant to the second allotment of the Offer. The issue price has been calculated by dividing the Company's latest published Net Asset Value of 82.40 pence per ordinary share as at 31 December 2019 by 0.9725 in accordance with the terms of the Offer.

Applications have been made for the New Shares to be issued pursuant to the Offer to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealing will commence in the New Shares to be issued pursuant to the Offer at 8.00 a.m. on 24 January 2020.

It is expected that share certificates in respect of the New Shares will be issued to the relevant Shareholders within 10 business days of the date of the second allotment.

Over Allotment Facility

Following the second allotment of shares under the Offer the Company has raised approximately £14.5 million. Following discussions with its advisers the Board has resolved to approve the use of the Company's Over Allotment Facility to raise an additional £5 million under the Offer.

Total voting rights

Each Ordinary Share has one voting right. Following the issue of New Shares pursuant to the Offer, the Company will have 265,595,151 Ordinary Shares in issue (of which 22,250,063 Ordinary Shares are held in treasury). The total number of voting rights in the Company will therefore be 243,345,088 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Further information

For further information please contact.

Baronsmead VCT Investor Relations

020 3875 9862

baronsmeadvcts@greshamhouse.com

 Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEBJMBTMTJTBFM
Date   Source Headline
3rd Jan 200810:04 amRNSDirector/PDMR Shareholding
3rd Jan 200810:00 amRNSDirector/PDMR Shareholding
31st Dec 200711:40 amRNSConversion of Securities
7th Dec 200712:00 pmRNSNet Asset Value(s)
29th Nov 200710:55 amRNSDividend Declaration
12th Nov 20074:41 pmRNSNet Asset Value(s)
12th Nov 20072:27 pmRNSNet Asset Value(s)
3rd Oct 20071:54 pmRNSDirector/PDMR Shareholding
3rd Oct 20071:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20071:44 pmRNSDirector/PDMR Shareholding
25th Sep 20072:37 pmRNSIssue of Equity
25th Sep 20072:34 pmRNSIssue of Equity
14th Sep 200710:58 amRNSNet Asset Value(s) - Amendmnt
7th Sep 20074:29 pmRNSNet Asset Value(s)
24th Aug 200712:24 pmRNSDoc re. Interim Report
24th Aug 200712:22 pmRNSIssue of Equity
17th Aug 200710:10 amRNSTransaction in Own Shares
15th Aug 200712:02 pmRNSNet Asset Value(s)
15th Aug 200710:40 amRNSInterim Results - Replacement
15th Aug 20079:44 amRNSInterim Results - Replacement
15th Aug 20077:30 amRNSInterim Results
29th Jun 20077:30 amRNSTransaction in Own Shares
11th Jun 200710:09 amRNSNet Asset Value(s)
16th May 200711:47 amRNSNet Asset Value(s)
15th May 20075:08 pmRNSNet Asset Value(s)-Amendment
15th May 20079:38 amRNSNet Asset Value(s)
3rd May 20075:45 pmRNSDirector/PDMR Shareholding
3rd May 20075:45 pmRNSDirector/PDMR Shareholding
3rd May 20075:45 pmRNSDirector/PDMR Shareholding
17th Apr 20073:42 pmRNSAGM Statement
30th Mar 20074:12 pmRNSTransaction in Own Shares
14th Mar 200710:12 amRNSHolding(s) in Company
13th Mar 20079:50 amRNSNet Asset Value(s)
6th Mar 20079:56 amRNSAnnual Information Update
6th Mar 20079:46 amRNSAnnual Report and Accounts
19th Feb 20073:15 pmRNSNet Asset Value(s)
12th Feb 20079:42 amRNSFinal Results
21st Dec 200612:18 pmRNSTotal Voting Rights
20th Dec 200612:42 pmRNSManagement Fee Arrangements
12th Dec 200610:04 amRNSManager Performance Incentive
8th Dec 20062:06 pmRNSNet Asset Value(s)
20th Nov 20063:42 pmRNSNet Asset Value(s)
8th Nov 20062:42 pmRNSNet Asset Value(s)
24th Oct 20064:02 pmRNSDirector/PDMR Shareholding
24th Oct 20063:56 pmRNSDirector/PDMR Shareholding
29th Sep 20064:25 pmRNSTransaction in Own Shares
11th Sep 20064:02 pmRNSNet Asset Value(s)
25th Aug 200611:00 amRNSDoc re. Interim Results
16th Aug 200610:33 amRNSTransaction in Own Shares
11th Aug 20062:51 pmRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.